The Sault Area Hospital is a medical facility in Sault Ste. Marie, Ontario.

There are 293 beds in Algoma District Cancer Program.

During the past decade, Algoma District Cancer Program conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 16 clinical trials were completed, i.e. on average, 94.1% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 8 clinical trials were completed. i.e. 133.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Algoma District Cancer Program" #1 sponsor was "NCIC Clinical Trials Group" with 13 trials, followed by "National Cancer Institute (NCI)" with 10 trials sponsored, "Canadian Cancer Trials Group" with 9 trials sponsored, "Ontario Clinical Oncology Group (OCOG)" with 3 trials sponsored and "Hoffmann-La Roche" with 3 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Algoma District Cancer Program" #1 collaborator was "SWOG Cancer Research Network" with 9 trials as a collaborator, "Cancer and Leukemia Group B" with 6 trials as a collaborator, "Eastern Cooperative Oncology Group" with 6 trials as a collaborator, "NRG Oncology" with 6 trials as a collaborator and "National Cancer Institute (NCI)" with 6 trials as a collaborator. Other collaborators include 60 different institutions and companies that were collaborators in the rest 45 trials.

According to Clinical.Site data, the most researched conditions in "Algoma District Cancer Program" are "Breast Cancer" (14 trials), "Lung Cancer" (3 trials), "Colorectal Cancer" (2 trials), "Fallopian Tube Clear Cell Adenocarcinoma" (2 trials) and "Fallopian Tube Transitional Cell Carcinoma" (2 trials). Many other conditions were trialed in "Algoma District Cancer Program" in a lesser frequency.

Most popular intervention types in "Algoma District Cancer Program" are "Drug" (35 trials), "Other" (20 trials), "Biological" (10 trials), "Procedure" (7 trials) and "Radiation" (6 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (6 trials), "Placebo" (5 trials), "placebo" (5 trials), "Computed Tomography" (4 trials) and "Laboratory Biomarker Analysis" (4 trials). Other intervention names were less common.

The vast majority of trials in "Algoma District Cancer Program" are 26 trials for "All" genders, 14 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Algoma District Cancer Program". undefined are not yet recruiting, 5 are recruiting, 13 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 24 completed trials in Algoma District Cancer Program, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Algoma District Cancer Program, 1 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 32 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".